SUMMARY Sixty strains of Haemophilus influenzae were isolated from the genitourinary tracts of adults: 19 from cervicovaginal secretions, one from a woman with bartholinitis, 37 from urethral exudates, and three from urine. Non-capsulated strains were recovered predominantly, and biotype III accounted for 28 isolates and biotype IV for 25.
isolated 60 strains of H influenzae from patients with genital and urinary tract infections. In the present study we classified the biotype and capsular serotype of these strains and investigated their susceptibility to eight antibiotics used for genital and urinary infections: ampicillin, chloramphenicol, tetracycline, minocycline, erythromycin, kanamycin, spectinomycin, and rosoxacin. We also assessed the usefulness of the following newer Most reports on the resistance of haemophili to antimicrobials deal with systemic or oropharyngeal infections, and few concern genitourinary isolates. In this study 18 (30%) strains were found to be resistant to one or several antibiotics. Resistance to tetracycline alone occurred in eight strains and associated with ampicillin resistance in nine strains. The two kanamycin resistant strains were also resistant to ampicillin and tetracycline. These numbers were higher than those reported in a nationwide French study in 1982 that excluded genitourinary isolates,32 and also than those reported by Albritton et ar9 and Wallace et at'3 in genital and neonatal H influenzae strains.
The production of TEMI like ,B lactamase was responsible for ampicillin resistance in the strains studied. We did not detect strains producing ROB-i ,B lactamase, the new type of plasmid determined / lactamase found in two H influenzae strains pathogenic to man and similar to the ROB-1 produced by the porcine pathogen H pleuropneumoniae.33 Neither did we identify ampicillin resistant non-f-lactamase producing H influenzae strains.34
Ofloxacin and ciprofloxacin may provide an effective alternative for the treatment of resistant H influenzae in genitourinary infections. They are also effective in vitro against genital pathogens such as N gonorrhoeae,35 H ducreyi,36 and to a lesser extent, C trachomatis37 and U urealyticum.38 Recent clinical trials with these compounds showed an excellent cure rate of gonococcal and non-gonococcal urethritis in men.`90 Further clinical studies with these agents in the treatment of STD seem to be warranted.
Few drugs are effective against both gonococcal and non-gonococcal genital infection, and tetracyclines are the most widely used. The high rate ofresistance to tetracycline alone (13%) or associated with resistance to other antibiotics as found in this study, has to be kept in mind because the common use of these antibiotics is likely to maintain a selective pressure on the genital bacteria. Studies have shown the spread of tetracycline resistance in, among other genera isolated from the genital tract, M hominis, U urealyticum, Gardnerella vaginalis," Streptococcus agalactiae,42 H ducreyi (Sanson-Le Pors MJ, et al, unpublished observation), and N gonorrhoeae.43
In conclusion, if we consider the possibility that the genitourinary tract environment favours plasmid transfer between bacterial species as well as genera, and as multiresistant strains of H influenzae appear to
